TTM
$44.40B
YoY change
+8.9%
5Y CAGR
+7.1%
Peak year (2025)
$42.96B
Cumulative gross profit
$425.01B
Gross Profit history chart for AbbVie (ABBV) from 2009 to 2025
Latest: $42.96B
Gross Profit growth chart for AbbVie (ABBV) from 2009 to 2025
Latest: +8.9%
Gross Profit history table for AbbVie (ABBV) from 2009 to 2025
| 2025 | $42.96B | +8.9% | +$3.53B | ||
| 2024 | $39.43B | +16.3% | +$5.53B | ||
| 2023 | $33.90B | -16.6% | −$6.74B | ||
| 2022 | $40.64B | +4.9% | +$1.89B | ||
| 2021 | $38.75B | +27.4% | +$8.33B | ||
| 2020 | $30.42B | +17.8% | +$4.59B | ||
| 2019 | $25.83B | +3.2% | +$792.00M | ||
| 2018 | $25.04B | +18.2% | +$3.86B | ||
| 2017 | $21.18B | +6.9% | +$1.37B | ||
| 2016 | $19.80B | +7.9% | +$1.45B | ||
| 2015 | $18.36B | +18.2% | +$2.83B | ||
| 2014 | $15.53B | +9.3% | +$1.32B | ||
| 2013 | $14.21B | +2.4% | +$337.00M | ||
| 2012 | $13.87B | +8.3% | +$1.07B | ||
| 2011 | $12.80B | +12.9% | +$1.46B | ||
| 2010 | $11.35B | +11.7% | +$1.19B | ||
| 2009 | $10.16B | — | — |
- 2025$42.96B+8.9%
- 2024$39.43B+16.3%
- 2023$33.90B-16.6%
- 2022$40.64B+4.9%
- 2021$38.75B+27.4%
- 2020$30.42B+17.8%
- 2019$25.83B+3.2%
- 2018$25.04B+18.2%
- 2017$21.18B+6.9%
- 2016$19.80B+7.9%
- 2015$18.36B+18.2%
- 2014$15.53B+9.3%
- 2013$14.21B+2.4%
- 2012$13.87B+8.3%
- 2011$12.80B+12.9%
- 2010$11.35B+11.7%
- 2009$10.16B—
Gross Profit values are taken from AbbVie's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's current gross profit (TTM) is $44.40B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, AbbVie (ABBV) gross profit totalled $42.96B – grew 8.9% year-over-year.
Looking at the 2020–2025 (5 years) stretch, AbbVie gross profit compounded at +7.1% per year, sustaining 2 straight years of year-over-year growth.
$42.96B stands as the all-time-high annual gross profit, posted in 2025, against a low of $10.16B during 2009.
AbbVie Gross Profit by Year
AbbVie Gross Profit 2025: $42.96B
2025's gross profit for AbbVie came in at $42.96B, grew 8.9% from 2024. This figure represents the highest annual value in the available history.
AbbVie Gross Profit 2024: $39.43B
AbbVie posted gross profit of $39.43B in 2024, grew 16.3% from 2023.
AbbVie Gross Profit 2023: $33.90B
In 2023, AbbVie reported gross profit of $33.90B, declined 16.6% below 2022.
AbbVie Gross Profit 2022: $40.64B
AbbVie gross profit in 2022 was $40.64B, edged up 4.9% from 2021.
AbbVie Gross Profit 2021: $38.75B
AbbVie gross profit in 2021 was $38.75B.
See more financial history for AbbVie (ABBV).
Sector peers by Gross Profit
Healthcare peers of AbbVie (ABBV), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $39.01B | |
| $26.01B | |
| $16.78B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $39.01B
- $26.01B
Frequently asked questions
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation